Caliway Biopharmaceuticals Co., Ltd. (TWSE: 6919), founded in 2012, is dedicated to developing breakthrough therapeutics that redefine standards of care and transform clinical practices.
PR Newswire news releases · 2026-11-20 13:14
証拠を見る
- 企業開示PR Newswire news releases2026-11-20 13:14
Caliway Biopharmaceuticals Co., Ltd. (TWSE: 6919), founded in 2012, is dedicated to developing breakthrough therapeutics that redefine standards of care and transform clinical practices.
出典を見る